Irinotecan/Ramucirumab Regimen

Preferred Label : Irinotecan/Ramucirumab Regimen;

NCIt synonyms : Irinotecan/Ramucirumab; Irinotecan/Cyramza Regimen; Irinotecan-Ramucirumab; Irinotecan-Ramucirumab Regimen; Irinotecan-Cyramza Regimen;

NCIt definition : A regimen consisting of irinotecan and ramucirumab that is used for the treatment of appendiceal adenocarcinoma, colon, esophageal and esophagogastric junction, gastric and rectal cancers.;

NCI Metathesaurus CUI : CL523571;

Détails

Origin ID

C136260;

UMLS CUI

C4526533;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Irinotecan Hydrochloride [NCIt concept]
- Ramucirumab [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Colorectal Carcinoma [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients